JP2007511582A5 - - Google Patents

Download PDF

Info

Publication number
JP2007511582A5
JP2007511582A5 JP2006540446A JP2006540446A JP2007511582A5 JP 2007511582 A5 JP2007511582 A5 JP 2007511582A5 JP 2006540446 A JP2006540446 A JP 2006540446A JP 2006540446 A JP2006540446 A JP 2006540446A JP 2007511582 A5 JP2007511582 A5 JP 2007511582A5
Authority
JP
Japan
Prior art keywords
group
pharmaceutical composition
alkyl
composition according
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006540446A
Other languages
English (en)
Japanese (ja)
Other versions
JP4824573B2 (ja
JP2007511582A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2004/052963 external-priority patent/WO2005049035A1/en
Publication of JP2007511582A publication Critical patent/JP2007511582A/ja
Publication of JP2007511582A5 publication Critical patent/JP2007511582A5/ja
Application granted granted Critical
Publication of JP4824573B2 publication Critical patent/JP4824573B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006540446A 2003-11-18 2004-11-15 腎不全、腎疾患または腎障害、特に糖尿病患者におけるこれらの治療のための医薬組成物 Expired - Fee Related JP4824573B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03104264.1 2003-11-18
EP03104264 2003-11-18
PCT/EP2004/052963 WO2005049035A1 (en) 2003-11-18 2004-11-15 Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients

Publications (3)

Publication Number Publication Date
JP2007511582A JP2007511582A (ja) 2007-05-10
JP2007511582A5 true JP2007511582A5 (cg-RX-API-DMAC10.html) 2007-11-22
JP4824573B2 JP4824573B2 (ja) 2011-11-30

Family

ID=34610099

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006540446A Expired - Fee Related JP4824573B2 (ja) 2003-11-18 2004-11-15 腎不全、腎疾患または腎障害、特に糖尿病患者におけるこれらの治療のための医薬組成物

Country Status (15)

Country Link
US (1) US7273860B2 (cg-RX-API-DMAC10.html)
EP (1) EP1687006B1 (cg-RX-API-DMAC10.html)
JP (1) JP4824573B2 (cg-RX-API-DMAC10.html)
CN (1) CN100566719C (cg-RX-API-DMAC10.html)
AR (1) AR046454A1 (cg-RX-API-DMAC10.html)
AT (1) ATE378053T1 (cg-RX-API-DMAC10.html)
AU (1) AU2004290925B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0416706A (cg-RX-API-DMAC10.html)
CA (1) CA2545802A1 (cg-RX-API-DMAC10.html)
DE (1) DE602004010172T2 (cg-RX-API-DMAC10.html)
ES (1) ES2297536T3 (cg-RX-API-DMAC10.html)
MX (1) MXPA06005547A (cg-RX-API-DMAC10.html)
PL (1) PL1687006T3 (cg-RX-API-DMAC10.html)
TW (1) TWI344366B (cg-RX-API-DMAC10.html)
WO (1) WO2005049035A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001036610A1 (en) * 1999-11-19 2001-05-25 Solvay Pharmaceuticals B.V. Human enzymes of the metalloprotease family
PE20060437A1 (es) 2004-06-18 2006-06-08 Novartis Ag COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR
GB0415746D0 (en) 2004-07-14 2004-08-18 Novartis Ag Organic compounds
US20060159748A1 (en) * 2004-12-23 2006-07-20 Rajesh Jain Oral immediate release formulation of a poorly water-soluble active substance
US11844803B2 (en) * 2017-12-11 2023-12-19 Aetas Pharma Co., Ltd. Renal dysfunction improving drug comprising optical isomer of 1,4-benzothiazepine-1-oxide derivative
PL424453A1 (pl) * 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Sposoby zmniejszania szkodliwego działania niedoboru perfuzji narządów miąższowych przez inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP)
ES2899200T3 (es) * 2018-06-22 2022-03-10 Synact Pharma Aps Tratamiento de proteinuria

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0254032A3 (en) * 1986-06-20 1990-09-05 Schering Corporation Neutral metalloendopeptidase inhibitors in the treatment of hypertension
DE19510566A1 (de) 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19638020A1 (de) * 1996-09-18 1998-03-19 Solvay Pharm Gmbh Die gastrointestinale Durchblutung fördernde Arzneimittel
DE19906310A1 (de) * 1999-02-16 2000-08-17 Solvay Pharm Gmbh Arzneimittel zur Behandlung von Bluthochdruck
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen
SE9903028D0 (sv) * 1999-08-27 1999-08-27 Astra Ab New use
IL162645A0 (en) * 2002-01-16 2005-11-20 Solvay Pharm Bv solid salts benzazepine compounds and their use inthe preparation of pharmaceuticals compounds
TW200306799A (en) * 2002-05-17 2003-12-01 Novartis Ag Combination of organic compounds

Similar Documents

Publication Publication Date Title
Gredic et al. Pulmonary hypertension in chronic obstructive pulmonary disease
ES2645726T3 (es) Formulación farmacéutica en forma de comprimidos bicapa que comprenden inhibidor de la HMG-CoA reductasa e irbesartán
RU2012117786A (ru) Новое производное фенола
JP2007508360A5 (cg-RX-API-DMAC10.html)
JP2010511631A5 (cg-RX-API-DMAC10.html)
JP2009519965A5 (cg-RX-API-DMAC10.html)
JP2011527332A5 (cg-RX-API-DMAC10.html)
JP2009531280A5 (cg-RX-API-DMAC10.html)
JP2004522714A5 (cg-RX-API-DMAC10.html)
JP2012533546A5 (cg-RX-API-DMAC10.html)
JP2005526696A5 (cg-RX-API-DMAC10.html)
RU2008151414A (ru) Соединение для лечения метаболических расстройств
JP2006143751A5 (cg-RX-API-DMAC10.html)
JP2008531520A5 (cg-RX-API-DMAC10.html)
JP2007522135A5 (cg-RX-API-DMAC10.html)
JP2015164972A5 (cg-RX-API-DMAC10.html)
JP2017506626A5 (cg-RX-API-DMAC10.html)
JP2009528275A5 (cg-RX-API-DMAC10.html)
WO2020018551A1 (en) Certain (2s)- n-[(1s)-1-cyano-2-phenylethyl]-1,4- oxazepane-2-carboxamides for treating inflammatory bowel disease
RU2006134022A (ru) Производные индазола и содержащие их фармацевтические композиции
JP2017536380A5 (cg-RX-API-DMAC10.html)
RU2012139463A (ru) Аминотиазолоны как модуляторы активности белков, родственных рецептору эстрогена альфа
RU2008139988A (ru) Применение производных 3,5-втор-4-норхолестана для получения лекарственного средства-цитопротектора
JP2010504321A5 (cg-RX-API-DMAC10.html)
RU2006113550A (ru) Циклогексильные производные, замещенные аминоалкиламидами